Clinical trial Recruiting at 1 site Interventional Ages 18 to 55 Men only

Fish oil supplementation to improve sperm quality in men

Official title: A Randomised, Double Blinded Study to Determine the Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality in Healthy Men.

Run by Epax Norway AS · NCT06950203 · Data updated 2026-11-12

This study is testing whether taking fish oil supplements can improve sperm quality in men who have low semen quality.

More Infertility, Male trials

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexMen only
Enrollment80 (estimated)
SponsorEpax Norway AS
Industry-sponsored
Locations1 site (Oslo)
StatusRecruiting
StartedMarch 10, 2025
Main results expectedSeptember 1, 2026
Study endsDecember 20, 2026
Registry record updatedMay 1, 2025
Trial IDNCT06950203 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are men aged 18-55 with documented poor sperm quality.

Probably not a fit

Patients with known allergies to fish products or specific medical conditions affecting sperm quality may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of fish oil supplementation on sperm quality in men with poor semen parameters. Participants will be randomly assigned to receive either fish oil capsules or a placebo for a duration of three months. Sperm samples will be collected at the beginning and end of the study to assess changes in quality. The study employs a double-blind design to ensure unbiased results, with both participants and assessors unaware of the treatment assignments.

Why it matters

Potential benefit: If successful, this study could provide a new dietary intervention to enhance male fertility.

How similar studies have gone: Previous studies have shown promising results with omega-3 fatty acids in improving sperm quality, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Men aged 18-55
2. Referred for or claiming a semen analysis.
3. Willing to have at least 2 days abstinence of sexual activity prior to a sperm sample being taken.
4. Reduced semen quality defined as:

   • Progressive motility: \<30%
5. Willing to refrain from omega-3/cod liver oil supplementation during the study. Use of other supplements is allowed.

   \-

Exclusion Criteria:

1. Known allergy to fish products
2. Historically, known, or suspected bacterial infection in reproductive organs
3. Varicocele suspected from physical examination
4. Azoospermia
5. Diagnosis of diabetes (type 2)
6. Diagnosis of Crohn´s Disease
7. Inferior semen quality due to medical reasons, such as cryptorchidism (via questionnaire/medical records) -

Where it's running

  • Medicus Group AS
    Oslo, Norway
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.